| Application no. and date | 05823474.1 (espacenet) (Federated) (European Patent Register), 20051220 | | Patent/reg. no. and date | DK/EP 1827461, 20120229 | | Publication date | 20070905 | | Priority no. and date | EP 04106909, 20041222, US 638669 P, 20041222 | | EP pub. no. and date |
EP 1827461 20070905 | | Effective date | | | Applicant/owner | Merck Serono SA, Centre Industriel
1267 Coinsins, Vaud, CH | | Applicant ref. no. | P49560DK01 | | Inventor | DE LUCA, Giampiero, Chemin de Conches 15B
CH-1231 Conches, CH,
LOPEZ-BRESNAHAN, Maria, 145 South Great Road
Lincoln, MA 01773, US,
YTHIER, Arnaud, Route de Vireloup 88
1239 Collex-Bossy, CH,
MUNAFO, Alain, Rue des Pressoirs 6
1180 Tartegnin, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/7076 (2006.01) , A61K 38/21 (2006.01) , A61P 25/00 (2006.01) | | Title | CLADRIBIN-REGIMEN TIL BEHANDLING AF MULTIPEL SKLEROSE | | Int. application no. | EP2005056954 | | Int. publication no. | WO2006067141 | | Related patent (certificate) | CA 2018 00010 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
